RO
Ross Osborn Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
18
Avg Return
Past Year
Past Year
3.6%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
94.4%
Neutral
5.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $13 |
65%
upside
| 2 | +5% |
0
%
| 6 Nov ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $32 |
56%
upside
| 1 | +68% |
0
%
| 29 Oct ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $9 |
226%
upside
| 2 | -19% |
0
%
| 8 Aug ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $95 |
14%
downside
| 1 | – |
–
| 6 Aug ‘25 7 months ago |
|
|
|
Overweight
Reiterated
| $25 |
78%
upside
| 2 | +2% |
0
%
| 5 Aug ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $12 |
166%
upside
| 2 | -17% |
0
%
| 31 Jul ‘25 7 months ago |
|
|
|
Overweight
Initiated
| $12 |
39%
upside
| 1 | +23% |
0
%
| 7 Jul ‘25 8 months ago |
|
|
|
Overweight
Maintained
| $7 |
107%
upside
| 1 | -42% |
0
%
| 15 May ‘25 9 months ago |
|
|
|
Overweight
Reiterated
| $2 |
37%
upside
| 2 | -1.7% |
0
%
| 15 May ‘25 9 months ago |
|
|
|
Overweight
Reiterated
| $17 |
21%
upside
| 2 | +16% |
0
%
| 14 May ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $9 |
232%
upside
| 1 | -46% |
0
%
| 1 Apr ‘25 11 months ago |
|
|
|
Overweight
Reiterated
| $46 |
122%
upside
| 1 | -34% |
0
%
| 26 Mar ‘25 11 months ago |
|